XOMA Royalty (XOMA) EBIT Growth (1y) (2012 - 2026)
XOMA Royalty (XOMA) EBIT Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -24.89% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 2,150.96% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 80.62% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 8.65% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 145.20% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | XOMA Royalty | 478.42 Mn | 412.34 Mn | - | -108.10% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -108.10% |
| Dec 31, 2025 | 130.08% |
| Jun 30, 2025 | 145.67% |
| Mar 31, 2025 | 184.65% |
| Dec 31, 2024 | 63.61% |
| Sep 30, 2024 | -170.26% |
| Jun 30, 2024 | -69.20% |
| Mar 31, 2024 | 31.13% |
| Dec 31, 2023 | -221.00% |
| Sep 30, 2023 | -32.37% |
| Jun 30, 2023 | -24.96% |
| Mar 31, 2023 | -392.49% |
| Dec 31, 2022 | -120.45% |
| Sep 30, 2022 | -30.70% |
| Jun 30, 2022 | -55.58% |
| Mar 31, 2022 | 67.87% |
| Dec 31, 2021 | 27.20% |
| Sep 30, 2021 | -24.40% |
| Jun 30, 2021 | 2.76% |
| Mar 31, 2021 | -14.44% |